美国德克萨斯大学安德森癌症中心的研究人员建立了一套二阶段的卵巢癌筛选方法,可以在疾病早期做出诊断。该方法主要是对血液中肿瘤标志蛋白CA125的水平的变化进行测量,从而可以更好地对癌症进行早期诊断。研究人员通过对11年来4000多名绝经后女性每年的CA125血液检测数据进行分析,并 Researchers at the Anderson Cancer Center at the University of Texas at Dallas have set up a two-stage ovarian cancer screening method that can be diagnosed early in the disease. This method is mainly to measure the level of tumor marker protein CA125 in blood, so that the cancer can be diagnosed early. Researchers through the 11 years to more than 4,000 postmenopausal women, the annual CA125 blood test data analysis and